Literature DB >> 11913066

Mouse and human dendritic cell subtypes.

Ken Shortman1, Yong-Jun Liu.   

Abstract

Dendritic cells (DCs) collect and process antigens for presentation to T cells, but there are many variations on this basic theme. DCs differ in the regulatory signals they transmit, directing T cells to different types of immune response or to tolerance. Although many DC subtypes arise from separate developmental pathways, their development and function are modulated by exogenous factors. Therefore, we must study the dynamics of the DC network in response to microbial invasion. Despite the difficulty of comparing the DC systems of humans and mice, recent work has revealed much common ground.

Entities:  

Mesh：

Year:  2002        PMID： 11913066     DOI： 10.1038/nri746

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN： 1474-1733            Impact factor:   53.106


  591 in total

1.  Cross-presentation of cell-associated antigens by CD8alpha+ dendritic cells is attributable to their ability to internalize dead cells.

Authors:  Oliver Schulz; Caetano Reis e Sousa
Journal:  Immunology       Date:  2002-10       Impact factor: 7.397

Review 2.  An overview on non-T cell pathways in transplant rejection and tolerance.

Authors:  Wentao Liu; Xian C Li
Journal:  Curr Opin Organ Transplant       Date:  2010-08       Impact factor: 2.640

3.  Structure and allosteric regulation of the alpha X beta 2 integrin I domain.

Authors:  Thomas Vorup-Jensen; Christian Ostermeier; Motomu Shimaoka; Ulrich Hommel; Timothy A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-28       Impact factor: 11.205

Review 4.  Dendritic cells, T cell tolerance and therapy of adverse immune reactions.

Authors:  P A Morel; M Feili-Hariri; P T Coates; A W Thomson
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

Review 5.  The plasmacytoid monocyte/interferon producing cells.

Authors:  Fabio Facchetti; William Vermi; David Mason; Marco Colonna
Journal:  Virchows Arch       Date:  2003-10-28       Impact factor: 4.064

6.  Targeting the intratumoral dendritic cells by the oncolytic adenoviral vaccine expressing RANTES elicits potent antitumor immunity.

Authors:  Natalia Lapteva; Melissa Aldrich; David Weksberg; Lisa Rollins; Tatiana Goltsova; Si-Yi Chen; Xue F Huang
Journal:  J Immunother       Date:  2009 Feb-Mar       Impact factor: 4.456

7.  Enforced expression of EBF in hematopoietic stem cells restricts lymphopoiesis to the B cell lineage.

Authors:  Zheng Zhang; Claudiu V Cotta; Robert P Stephan; Cristina G deGuzman; Christopher A Klug
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

8.  Vaccinia virus-mediated inhibition of type I interferon responses is a multifactorial process involving the soluble type I interferon receptor B18 and intracellular components.

Authors:  Zoe Waibler; Martina Anzaghe; Theresa Frenz; Astrid Schwantes; Christopher Pöhlmann; Holger Ludwig; Marcos Palomo-Otero; Antonio Alcamí; Gerd Sutter; Ulrich Kalinke
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

9.  Paradoxical effects of interleukin-10 on the maturation of murine myeloid dendritic cells.

Authors:  Dianne L Commeren; Peter L Van Soest; Khalil Karimi; Bob Löwenberg; Jan J Cornelissen; Eric Braakman
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

10.  Effect of the poly(ethylene glycol) (PEG) density on the access and uptake of particles by antigen-presenting cells (APCs) after subcutaneous administration.

Authors:  Xi Zhan; Kenny K Tran; Hong Shen
Journal:  Mol Pharm       Date:  2012-11-20       Impact factor: 4.939
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.